Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.
Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I.
Fitzgerald DJ, et al. Among authors: pastan i.
Leuk Lymphoma. 2011 Jun;52 Suppl 2(Suppl 2):79-81. doi: 10.3109/10428194.2011.569961.
Leuk Lymphoma. 2011.
PMID: 21599608
Free PMC article.
Review.